Literature DB >> 24185079

Two novel mutations in the SLCO2A1 gene in a Chinese patient with primary hypertrophic osteoarthropathy.

Zeng Zhang1, Jin-Wei He2, Wen-Zhen Fu2, Chang-Qing Zhang3, Zhen-Lin Zhang4.   

Abstract

Primary hypertrophic osteoarthropathy (PHO) is a rare monogenetic disease characterized by digital clubbing, periostosis and pachydermia. Mutations in the 15-hydroxy-prostaglandin dehydrogenase (HPGD) gene and solute carrier organic anion transporter family member 2A1 (SLCO2A1) gene have been shown to be associated with PHO. Here, we described clinical characteristics in a Chinese patient with PHO, and identified two novel mutations in SLCO2A1: a heterozygous guanine-to-thymidine transition at the invariant -1 position of the acceptor site of intron 2 (c.235-1G>T) and a heterozygous missense mutation p.Pro219Leu (c.656C>T) in exon 5.
© 2013.

Entities:  

Keywords:  HGMD; HPGD; Human Gene Mutation Database; Hydroxyprostaglandin dehydrogenase 15-(NAD); PCR; PGE-M; PGE2; PGEM; PGT; PHO; PHOAR1; PHOAR2; Pachydermoperiostosis; Polymerase chain reaction; Primary hypertrophic osteoarthropathy; Primary hypertrophic osteoathropathy autosomal recessive 1; Primary hypertrophic osteoathropathy autosomal recessive 2; Prostaglandin E metabolite; Prostaglandin E2; Prostaglandin transporter; SLCO2A1; Solute carrier organic anion transporter family, member 2A1; Transporter

Mesh:

Substances:

Year:  2013        PMID: 24185079     DOI: 10.1016/j.gene.2013.10.051

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  10 in total

Review 1.  Roles of Organic Anion Transporting Polypeptide 2A1 (OATP2A1/SLCO2A1) in Regulating the Pathophysiological Actions of Prostaglandins.

Authors:  Takeo Nakanishi; Ikumi Tamai
Journal:  AAPS J       Date:  2017-12-04       Impact factor: 4.009

2.  The organic anion transporter SLCO2A1 constitutes the core component of the Maxi-Cl channel.

Authors:  Ravshan Z Sabirov; Petr G Merzlyak; Toshiaki Okada; Md Rafiqul Islam; Hiromi Uramoto; Tomoko Mori; Yumiko Makino; Hiroshi Matsuura; Yu Xie; Yasunobu Okada
Journal:  EMBO J       Date:  2017-10-18       Impact factor: 11.598

Review 3.  The Prostaglandin Transporter: Eicosanoid Reuptake, Control of Signaling, and Development of High-Affinity Inhibitors as Drug Candidates.

Authors:  Victor L Schuster; Yuling Chi; Run Lu
Journal:  Trans Am Clin Climatol Assoc       Date:  2015

4.  Inhibition of the Prostaglandin Transporter PGT Lowers Blood Pressure in Hypertensive Rats and Mice.

Authors:  Yuling Chi; Jean-Francois Jasmin; Yoshinori Seki; Michael P Lisanti; Maureen J Charron; David J Lefer; Victor L Schuster
Journal:  PLoS One       Date:  2015-06-29       Impact factor: 3.240

5.  Identification of two novel mutations in the SLCO2A1 prostaglandin transporter gene in a Chinese patient with primary hypertrophic osteoarthropathy.

Authors:  Ting Guo; Kai Yang; Lv Liu; Zhi-Ping Tan; Hong Luo
Journal:  Mol Med Rep       Date:  2017-03-24       Impact factor: 2.952

6.  Characterization of Mineral and Bone Metabolism Biomarkers in a Chinese Consanguineous Twin Family with Primary Hypertrophic Osteoarthropathy.

Authors:  Na Li; Yuhang Ma; Yun Jiang; Li You; Yunhong Huang; Yongde Peng; Xiaoying Ding; Li Zhao
Journal:  Int J Endocrinol       Date:  2020-12-03       Impact factor: 3.257

Review 7.  The ATP-Releasing Maxi-Cl Channel: Its Identity, Molecular Partners and Physiological/Pathophysiological Implications.

Authors:  Ravshan Z Sabirov; Md Rafiqul Islam; Toshiaki Okada; Petr G Merzlyak; Ranokhon S Kurbannazarova; Nargiza A Tsiferova; Yasunobu Okada
Journal:  Life (Basel)       Date:  2021-05-31

8.  Identification of the Mutations in the Prostaglandin Transporter Gene, SLCO2A1 and Clinical Characterization in Korean Patients with Pachydermoperiostosis.

Authors:  Sihoon Lee; So Young Park; Hyun Jin Kwon; Chul-Ho Lee; Ok-Hwa Kim; Yumie Rhee
Journal:  J Korean Med Sci       Date:  2016-03-22       Impact factor: 2.153

9.  Novel SLCO2A1 mutations cause gender differentiated pachydermoperiostosis.

Authors:  Lijuan Yuan; Xihui Chen; Ziyu Liu; Dan Wu; Jianguo Lu; Guoqiang Bao; Sijia Zhang; lIfeng Wang; Yuanming Wu
Journal:  Endocr Connect       Date:  2018-08-01       Impact factor: 3.335

10.  Pachydermoperiostosis Associated with Myelofibrosis: A Rare Case Report.

Authors:  Pedro Secchin; Nurimar C Fernandes; Danielle C Quintella; Juliano A R Silva; Juliana Medrado; Taissa C Magalhães
Journal:  Indian J Dermatol       Date:  2019 Nov-Dec       Impact factor: 1.494

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.